Congress·In Committee·H.R. 7953

To accelerate patient access to innovative medicines and clinical trials for life-threatening diseases by establishing a reciprocal approval mechanism with trusted international regulatory authorities.

Legislative Progress

House

Senate

President

Law

2 milestones2 actions

Mar 17, 2026House

Referred to the House Committee on Energy and Commerce.

Mar 17, 2026

Introduced in House

Document Type

Congressional Bill

Bill NumberHR 7953

Congress119th Congress

ChamberHouse of Representatives

Latest ActionReferred to the House Committee on Energy and Commerce.

Congress.gov

Official legislative information

(1)

D: 1

Analysis generated by AI. Always verify with official sources.